Sleep apnea is a stronger predictor for coronary heart disease than traditional risk factors

Sleep and Breathing

Volumn 16, Issue 3, 2012, Pages 695-701

  Martinez, Denis ^a   Klein, Cristini ^a   Rahmeier, Laura ^b   Silva, Roberto Pacheco Da ^b   Fiori, Cintia Zappe ^b   Cassol, Cristiane Maria ^a   Gonçalves, Sandro Cadaval ^a   Bos, Angelo Jose Goncalves ^c  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Angina; Cardiovascular disease; Coronary angiography; Coronary artery disease; Polysomnography; Sleep apnea

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ANGIOCARDIOGRAPHY; APNEA HYPOPNEA INDEX; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; PREDICTION; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING;

AMBULATORY CARE; BODY MASS INDEX; BRAZIL; CAUSALITY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYSOMNOGRAPHY; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84867574872     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-011-0559-0     Document Type: Article

References (39)

1. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 8:686-717
2. Crummy F, Piper AJ, Naughton MT (2008) Obesity and the lung: Obesity and sleep-disordered breathing. Thorax 8:738-746
3. Devulapally K, Pongonis R Jr, Khayat R (2009) OSA: the new cardiovascular disease: part II: overview of cardiovascular diseases associated with obstructive sleep apnea. Heart Fail Rev 3:155-164
4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, Heart N, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VII). J Am Med Assoc 289:2560-2572
5. Lüthje L, Andreas S (2008) Obstructive sleep apnea and coronary artery disease. Sleep Med Rev 1:19-31
6. Nelson CA, Wolk R, Somers VK (2005) Sleep-disordered breathing: implications for the pathophysiology and management of cardiovascular disease. Compr Ther 1:21-27
7. Leung RS (2009) Sleep-disordered breathing: autonomic mechanisms and arrhythmias. Prog Cardiovasc Dis 4:324-338
8. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 19:2034-2041
9. Gami AS, Howard DE, Olson EJ, Somers VK (2005) Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 12:1206-1214
10. McNicholas WT, Bonsigore MR (2007) Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 1:156-178
11. Butt M, Dwivedi G, Khair O, Lip GY (2010) Obstructive sleep apnea and cardiovascular disease. Int J Cardiol 1:7-16
12. Gottlieb DJ, Yenokyan G, Newman AB, O'Connor GT, Punjabi NM, Quan SF, Redline S, Resnick HE, Tong EK, Diener-West M, Shahar E (2010) Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure. The Sleep Heart Health Study. Circulation 4:352-360
13. Peker Y, Kraiczi H, Hedner J, Löth S, Johansson A, Bende M (1999) An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 1:179-184
14. Klein C, Martinez D, Hackenhaar FS, Medeiros TM, Marcolin ML, Silveira FS, Wainstein MV, Gonçalvez SC, Benfato MS (2010) Carbonyl groups: bridging the gap between sleep disordered breathing and coronary artery disease. Free Radic Res 8:907-912
15. Tonelli de Oliveira AC,Martinez D, Vasconcelos LF, Gonçalves SC, Lenz MC, Fuchs SC, Gus M, Abreu-Silva EO, Moreira LB, Fuchs FD (2009) Diagnosis of obstructive sleep apnea syndrome and its outcomes with home portable monitoring. Chest 2:330-336
16. American Academy of Sleep Medicine (2005) International classification of sleep disorders. Diagnostic and coding manual (ICSD-2). 2nd ed. Westchester, I.L.
17. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL (2002) Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 5:677-682
18. Lear SA, Chen MM, Birmingham CL, Frohlich JJ (2003) The relationship between simple anthropometric indices and Creactive protein: ethnic and gender differences. Metabolism 12:1542-1546
19. Ryan S, Taylor CT, McNicholas WT (2009) Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax 7:631-636
20. Steiropoulos P, Kotsianidis I, Nena E, Tsara V, Gounari E, Hatzizisi O, Kyriazis G, Christaki P, Froudarakis M, Bouros D (2009) Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome. Sleep 4:537-543
21. Taheri S, Austin D, Lin L, Nieto FJ, Young T, Mignot E (2007) Correlates of serum C-reactive protein (CRP) -no association with sleep duration or sleep disordered breathing. Sleep 8:991-996
22. Kao TW, Lu IS, Liao KC, Lai HY, Loh CH, Kuo HK (2009) Associations between body mass index and serum levels of Creactive protein. S Afr Med J 5:326-330
23. Kono M, Tatsumi K, Saibara T, Nakamura A, Tanabe N, Takiguchi Y, Kuriyama T (2007) Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 5:1387-1392
24. Drager LF, Bortolotto LA, Maki-Nunes C, Trombetta IC, Alves MJ, Fraga RF, Negrão CE, Krieger EM, Lorenzi-Filho G (2010) The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome. Atherosclerosis 2:490-495
25. Roche F, Sforza E, Pichot V, Maudoux D, Garcin A, Celle S, Picard-Kossovsky M, Gaspoz JM, Barthélémy JC, PROOF Study Group (2009) Obstructive sleep apnoea/hypopnea influences high-density lipoprotein cholesterol in the elderly. Sleep Med 8:882-886
26. Gonçalves SC, Martinez D, Gus M, de Abreu-Silva EO, Bertoluci C, Dutra I, Branchi T, Moreira LB, Fuchs SC, de Oliveira AC, Fuchs FD (2007) Obstructive sleep apnea and resistant hypertension: a case-control study. Chest 6:1858-1862
27. Lopez-Jimenez F, Sert Kuniyoshi FH, Gami A, Somers VK (2008) Obstructive sleep apnea: implications for cardiac and vascular disease. Chest 3:793-804
28. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA (2010) Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res 2:170-180
29. Lavie L, Hefetz A, Luboshitzky R, Lavie P (2003) Plasma levels of nitric oxide and L-arginine in sleep apnea patients: effects of nCPAP treatment. J Mol Neurosci 1:57-63
30. Gagliardi AC, Miname MH, Santos RD (2009) Uric acid: a marker of increased cardiovascular risk. Atherosclerosis 1:11-17
31. Tsai WC, Huang YY, Lin CC, Li WT, Lee CH, Chen JY, Chen JH (2009) Uric acid is an independent predictor of arterial stiffness in hypertensive patients. Heart Vess 5:371-375. doi:10.1007/s00380-008-1127-9
32. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF (2007) Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 7:706-712
33. De Luis DA, González Sagrado M, Conde R, Aller R, Izaola O (2010) Resistin levels and inflammatory markers in patients with morbid obesity. Nutr Hosp 4:630-634
34. Chami HA, Resnick HE, Quan SF, Gottlieb DJ (2011) Association of incident cardiovascular disease with progression of sleepdisordered breathing. Circulation 12:1280-1286
35. Martinez D, da Silva RP, Klein C, Fiori CZ, Massierer D, Cassol CM, Bos AJ, Gus M (2011) High risk for sleep apnea in the Berlin questionnaire and coronary artery disease. Sleep and Breathing 6. doi:10.1007/s11325-010-0460-2
36. Dempsey JA, Veasey SC, Morgan BJ, O'Donnell CP (2010) Pathophysiology of sleep apnea. Physiol Rev 1:47-112
37. Kohli P, Balachandran JS, Malhotra A (2011) Obstructive sleep apnea and the risk for cardiovascular disease. Curr Atheroscler Rep 2:138-146
38. Hui DS, Ko FW, Fok JP, Chan MC, Li TS, Tomlinson B, Cheng G (2004) The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest 5:1768-1775
39. Yumino D, Redolfi S, Ruttanaumpawan P, Su MC, Smith S, Newton GE, Mak S, Bradley TD (2010) Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 14:1598-1605